Nihalani, Deepak
- Medical University of South Carolina · Internal Medicine (NIH department code)
- Indepth Pharmaceuticals, LLC (no department on record)
From the FY2019 NIH awards this investigator leads as contact PI. The department is the award's.
FY2019 NIH rank #30,641
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2019Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2019 award categories
- Internal Medicine
NIH Funding · FY2019
Linked Award Amount
$299K
Full award amounts, FY2019
Award Records
2
Records listing this PI
Award-Linked Rank
#30,641
By linked amount among FY2019 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2019 award records by amount
NIH award records listing Nihalani, Deepak as a PI. Multi-PI records show the full award amount for context.
- 1R41DK118999-01A1R41Contact PIDeveloping and validating a podocyte cell-based diagnostic assay for identifying recurrent focal and segmental glomerulosclerosis patients$224.3Kaward amount
- 1R03TR003038-01R03Contact PIClinical Assessment of a novel non-invasive assay for diagnosing recurrent focal and segmental glomerulosclerosisMedical University of South Carolina · Internal Medicine (NIH department code)$74.8Kaward amount
Award organizations
Organizations that administered FY2019 awards listing Nihalani, Deepak as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardIndepth Pharmaceuticals, LLC
- 2007Multi-Institutional ResearchAwards at 2 institutions
- 2009$500K Cumulative Funding
- 2010$1M Cumulative Funding
- 2014$2M Cumulative Funding